Vimarsana
Biggest News Aggregation in the World

Use Thereof News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Use Thereof. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Use Thereof Today - Breaking & Trending Today

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments - Vimarsana News

BrainStorm Granted Patents for Allogeneic Exosome Platform-Product in Neurological Disorder Treatments

NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Brainstorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today provided an update on the grant...

Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - A10 Networks (NYSE:ATEN), AgileThought (NASDAQ:AGIL) - Vimarsana News

Why Brooge Energy Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket - A10 Networks (NYSE:ATEN), AgileThought (NASDAQ:AGIL)

Gainers

PVA Solidifies Optical Bonding Expertise with New Patent - Vimarsana News

PVA Solidifies Optical Bonding Expertise with New Patent

PVA, a global supplier of automated dispensing and coating equipment, is pleased to announce that it has been awarded a new patent for optical bonding.

Source: azom.com
Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives - Vimarsana News

Ascletis Announces Notice of Issuance of the U.S. Patent for Oral Viral Polymerase Inhibitor ASC10 and Its Derivatives

--The issue date of the patent will be January 3, 2023 by the United States Patent and Trademark Office (USPTO). The patent number is 11,541,071 -- The issued...

AstraZeneca Sues Pharmaceutical Companies Over Generic Hyperkalemia Treatment - Vimarsana News

AstraZeneca Sues Pharmaceutical Companies Over Generic Hyperkalemia Treatment

Plaintiffs ZS Pharma, Inc. and AstraZeneca Pharmaceuticals LP filed suit on Monday in the District of Delaware against defendants Ascent Pharmaceuticals